Indobufen and Aspirin Hypersensitivity: A Promising Alternative or a Limited Option? [0.03%]
吲哚布芬作为阿司匹林过敏患者的替代药物:前景广阔还是选择有限?
Marco Giuseppe Del Buono,Simone Filomia,Alessia DAiello et al.
Marco Giuseppe Del Buono et al.
Finerenone Proves Beneficial for Heart Failure With Preserved Ejection Fraction, Erratum [0.03%]
非奈酮对射血分数保留的心力衰竭有益 的修正案
Giuseppe Biondi-Zoccai,Mattia Galli,George W Booz
Giuseppe Biondi-Zoccai
Coupling Interval Ratio to Predict the Beta Blocker Response against Premature Ventricular Complexes [0.03%]
通过联结RR间期比率预测β阻滞剂对室性早搏的反应
Hasan Atmaca,Ertan Yetkin
Hasan Atmaca
Despite the wide-spread use of beta blockers, unpredictable response and overall low efficacy are the major pitfalls of beta blocker use for premature ventricular complexes (PVC). Accordingly, we aimed to reveal Holter-guided electrocardiog...
Pantothenate Kinase 1 (PANK1) Identified as a Direct Target of SGLT2 Inhibitors in the Heart [0.03%]
心脏中SGLT2抑制剂的直接靶点PANTOTHENATE KINASE 1(PANK1)被鉴定出来
Ghadir Amin,George W Booz,Fouad A Zouein
Ghadir Amin
The 5-HT7 receptor contributes to increased hindquarter blood flow caused by skeletal muscle contraction [0.03%]
骨骼肌收缩引起的后肢血流增加中的5-HT7受体作用
Teresa Krieger-Burke,Elise Yoder,Jefferson C Frisbee et al.
Teresa Krieger-Burke et al.
Serotonin (5-hydroxytryptamine, 5-HT) at low plasma concentrations reduces blood pressure and dilates some skeletal muscle arterioles in the rat. We hypothesized that the 5-HT7 receptor is essential for both 5-HT-induced changes in blood pr...
Cardiac Immunotherapy, Immuno-Cardiology and the Future of Cardiovascular Pharmacology [0.03%]
心脏免疫疗法,免疫心脏病学以及心血管药理学的未来
Giuseppe Biondi-Zoccai,Brittany N Weber,Antonio Abbate et al.
Giuseppe Biondi-Zoccai et al.
Immuno-cardiology is an emerging field that explores the interplay between the immune system, inflammation and cardiovascular health/disease, aiming to develop innovative therapies for preventing and treating cardiac diseases. Indeed, chron...
Deciphering the Role of In-hospital Bleeding in Acute Coronary Syndromes [0.03%]
解读住院出血在急性冠状动脉综合征中的作用
Felice Gragnano,Paolo Calabrò,Dominick J Angiolillo
Felice Gragnano
Decastatin, a novel Non-Collagenous 1 domain from collagen type X, harbors a specific fragment with antiangiogenic properties [0.03%]
新型非胶原蛋白1区肽decastatin具有抗血管生成功效的片段成分研究
Signe Marie Jansen,Rastislav Pitek,Morten Asser Karsdal et al.
Signe Marie Jansen et al.
The NC1 domains of collagens have been shown to possess antiangiogenic potential and, therefore, are of therapeutic interest for cancer. However, endostatin and other NC1 domains have not been successful in clinical tests. Therefore, we use...
Role of Indobufen in coronary artery disease: the story of a neglected drug. A systematic review [0.03%]
吲布芬在冠心病治疗中的作用:一种被忽视的药物的故事。系统性综述
Martino Pepe,Rocco Tritto,Gianluigi Napoli et al.
Martino Pepe et al.
The management of antiplatelet therapy in coronary artery disease (CAD) is one of the most debated topics in cardiology. In some clinical scenarios, such as acute coronary syndromes (ACS) and/or percutaneous coronary interventions (PCI), a ...
Relationship between ALDH2 Gene Polymorphism and Vasodilative Effect of Nitroglycerin on Coronary Arteries [0.03%]
ALDH2基因多态性与硝酸甘油扩张冠状动脉效应的关系研究
Kai Zhang,Chi He,Yaliang Tong et al.
Kai Zhang et al.
Aldehyde dehydrogenase 2 (ALDH2) is a key enzyme that facilitates the biological metabolism of nitroglycerin. However, no study investigated the association between ALDH2 gene polymorphism and the vasodilation of coronary arteries following...